Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY-NCPharmaceutical biology

Aqueous extract of erigeron annuus ameliorates OVA-induced atopic dermatitis-like skin lesions through modulation of Th2-mediated immune responses and MAPK signaling.

  1. 1Functional Platform Research Group, Research, Korea Food Research Institute, Wanju-gun, Jeonbuk State, Republic of Korea.
  2. 2Department of Food Science and Nutrition, Dankook University, Cheonan, Korea.
  3. 3Hamsoa Pharmaceutics, Iksan, Jeonbuk State, Republic of Korea.

Abstract

Context

Atopic dermatitis is a chronic inflammatory skin disorder characterized by epidermal barrier dysfunction and dysregulated type 2 helper T cell (Th2)-mediated immune responses. Erigeron annuus (L.) Desf. is traditionally used for inflammatory conditions, but its effects on atopic dermatitis remain unclear.Objective

This study evaluated the protective effects of E. annuus aqueous extract (EA) and associated mechanisms.Materials and methods

Atopic dermatitis-like lesions were induced in 5-week-old female BALB/c mice by repeated epicutaneous ovalbumin (OVA) sensitization, and EA was orally administered for six weeks. Epidermal barrier function, histopathology, immunoglobulins, cytokines, and mitogen-activated protein kinase (MAPK) signaling were evaluated. Pyromeconic acid (PA), a representative constituent of EA, was examined in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.Results

EA attenuated dermatitis-like lesions and reduced dermatitis scores in OVA-sensitized mice. EA decreased transepidermal water loss, increased skin hydration, restored filaggrin expression, and reduced epidermal and dermal thickening, mast cell infiltration, CD4⁺/CD8⁺ T-cell accumulation, splenomegaly, serum total and OVA-specific IgE, and skin interleukin-4 and interleukin-13 levels. EA also reduced extracellular signal-regulated kinase and p38 phosphorylation and interleukin-1β expression in dorsal skin. PA suppressed MAPK activation and inflammatory mediator expression in LPS-stimulated macrophages.Discussion and conclusion

EA attenuated OVA-induced atopic dermatitis-like inflammation in association with improved epidermal barrier function, reduced Th2-associated immune responses, and attenuated MAPK signaling. PA showed anti-inflammatory activity in vitro, although its contribution to the in vivo effects of EA remains to be established. EA warrants further investigation as a plant-derived candidate for complementary intervention in atopic dermatitis.

Related

  1. Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling
    Ronak Patel, Rong Cheng, Christopher L. Cardona +11
    GliaPeer-reviewedCC BY5 citedNeuroscienceOpenAlex
  2. Modulation of pentraxin 3 by vinpocetine ameliorates lung Inflammation in murine model of allergic asthma exacerbated by lipopolysaccharide
    Won Seok Choi, Jin Yong Song, Bomi Yoon +2
    Biology DirectPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyPMC
  3. γ-Secretase inhibitor ameliorates thyroid autoimmune damage via blocking Notch1 signaling and reducing γδT17 cells in EAT mice
    Jue Wang, Longfei Ding, Chengyan He +5
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textImmunologyJ-STAGE
  4. Betulinic acid ameliorates lipopolysaccharide-induced intestinal barrier dysfunction in broilers by remodeling gut microbiota homeostasis and inhibiting the LYG2/NOD1/NF-κB signaling axis.
    Zhaoping Ou, Wenjiang Yang, Wenyu Ba +10
    Poultry sciencePeer-reviewedCC BY-NC-NDFull textZoology & animal behaviourEurope PMC
  5. The complete chloroplast genome of Erigeron sumatrensis (Asteraceae): genomic features and phylogenetic implications
    Yu Liu, Xin Wei, Jing Li +3
    Mitochondrial DNA. Part B, ResourcesPeer-reviewedCC BYFull textGeneral biologyEurope PMC
BibTeX
@article{ahn2026aqueous,
  title = {{Aqueous extract of erigeron annuus ameliorates OVA-induced atopic dermatitis-like skin lesions through modulation of Th2-mediated immune responses and MAPK signaling.}},
  author = {Yejin Ahn and Min Ji Gu and Ho-Young Park and Seol Ji Baek and Seong Un Jeong and Sang Keun Ha and Donghwan Kim},
  journal = {Pharmaceutical biology},
  year = {2026},
  month = oct,
  doi = {10.1080/13880209.2026.2748088},
  url = {https://europepmc.org/article/MED/42885539},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Aqueous extract of erigeron annuus ameliorates OVA-induced atopic dermatitis-like skin lesions through modulation of Th2-mediated immune responses and MAPK signaling.
AU  - Yejin Ahn
AU  - Min Ji Gu
AU  - Ho-Young Park
AU  - Seol Ji Baek
AU  - Seong Un Jeong
AU  - Sang Keun Ha
AU  - Donghwan Kim
PY  - 2026
DA  - 2026/10/16
JO  - Pharmaceutical biology
DO  - 10.1080/13880209.2026.2748088
UR  - https://europepmc.org/article/MED/42885539
AB  - Context  Atopic dermatitis is a chronic inflammatory skin disorder characterized by epidermal barrier dysfunction and dysregulated type 2 helper T cell (Th2)-mediated immune responses. Erigeron annuus (L.) Desf. is traditionally used for inflammatory conditions, but its effects on atopic dermatitis remain unclear.Objective  This study evaluated the protective effects of E. annuus aqueous extract (EA) and associated mechanisms.Materials and methods  Atopic dermatitis-like lesions were induced in 5-week-old female BALB/c mice by repeated epicutaneous ovalbumin (OVA) sensitization, and EA was orally administered for six weeks. Epidermal barrier function, histopathology, immunoglobulins, cytokines, and mitogen-activated protein kinase (MAPK) signaling were evaluated. Pyromeconic acid (PA), a representative constituent of EA, was examined in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.Results  EA attenuated dermatitis-like lesions and reduced dermatitis scores in OVA-sensitized mice. EA decreased transepidermal water loss, increased skin hydration, restored filaggrin expression, and reduced epidermal and dermal thickening, mast cell infiltration, CD4⁺/CD8⁺ T-cell accumulation, splenomegaly, serum total and OVA-specific IgE, and skin interleukin-4 and interleukin-13 levels. EA also reduced extracellular signal-regulated kinase and p38 phosphorylation and interleukin-1β expression in dorsal skin. PA suppressed MAPK activation and inflammatory mediator expression in LPS-stimulated macrophages.Discussion and conclusion  EA attenuated OVA-induced atopic dermatitis-like inflammation in association with improved epidermal barrier function, reduced Th2-associated immune responses, and attenuated MAPK signaling. PA showed anti-inflammatory activity in vitro, although its contribution to the in vivo effects of EA remains to be established. EA warrants further investigation as a plant-derived candidate for complementary intervention in atopic dermatitis.
SN  - 1388-0209
SN  - 1744-5116
ER  -